Skip to content
HowShorted

How shorted is Candel Therapeutics, Inc.? CADL

#253most shorted US stockof 3,805 ranked stocks, more shorted than 93%

16.13%
of shares outstanding reported short · settlement date 15 Sep 2026
vs previous report
+0.10
5 reports (~10 weeks)
−5.90
days to cover
10.28
Aggregate net short position time series for Candel Therapeutics, Inc.

Markers along the chart's base: ▲ results announced (an 8-K reporting results was filed) ▲ quarterly or annual report filed. Dates are SEC filing dates; hover a point to see events since the previous settlement.

Days to cover

FINRA's own figure: reported shares short divided by the stock's average daily trading volume, published alongside each settlement. It expresses the short position in days of typical trading rather than as a percentage of the company; the two can move differently.

Aggregate net short position time series for Candel Therapeutics, Inc. days to cover

Short interest around results

For each results announcement (an 8-K reporting results, by its SEC filing date), the FINRA settlement before it and the first one after. Settlements fall twice a month, so the two figures can sit up to a month apart and much else changes in between: this shows what was reported, not why.

Reported short interest before and after each results announcement
Results filedSettlement beforeSettlement afterChange
13 Aug 202617.28% 31 Jul 202616.29% 14 Aug 2026−0.99
14 May 202620.04% 30 Apr 202619.69% 15 May 2026−0.35
12 Mar 202623.65% 27 Feb 202619.36% 13 Mar 2026−4.29
19 Feb 202616.93% 13 Feb 202623.65% 27 Feb 2026+6.72
13 Nov 202513.63% 31 Oct 202515.20% 14 Nov 2025+1.57
14 Oct 202513.16% 30 Sep 202513.61% 15 Oct 2025+0.45
14 Aug 202513.69% 31 Jul 202512.28% 15 Aug 2025−1.41
13 May 202511.41% 30 Apr 202513.16% 15 May 2025+1.75

Fails to deliver

The SEC's fails-to-deliver figure for CADL: the aggregate net balance of shares that failed to be delivered at each settlement date, published by the SEC twice a month and shown here verbatim for the trailing window. A balance is not a daily flow, and a fail has many ordinary causes; the SEC says it cannot guarantee the accuracy of the data. See what fails to deliver are and the largest balances today.

Last balance on file
117,062
11 Sep 2026
Highest in window
117,062
11 Sep 2026
Days with a balance
114
Window
16 Sep 2025 to 14 Sep 2026
Aggregate net short position time series for Candel Therapeutics, Inc. fails to deliver

Source: U.S. Securities and Exchange Commission, fails-to-deliver data (public domain). Only settlement days with a positive balance appear; the largest balance in the window was 117K shares.

Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

Download chart cardShare on XRedditLinkedIn
Cite this page
Plain
Wikipedia
BibTeX

Sector: Healthcare · By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

History

Full reported short interest history
Settlement dateShort %Change
15 Sep 202616.13%+0.10
31 Aug 202616.03%−0.26
14 Aug 202616.29%−0.99
31 Jul 202617.28%−0.42
15 Jul 202617.70%−4.33
30 Jun 202622.03%+3.44
15 Jun 202618.59%−0.75
29 May 202619.34%−0.35
15 May 202619.69%−0.35
30 Apr 202620.04%−0.53
15 Apr 202620.57%+0.34
31 Mar 202620.23%+0.87
13 Mar 202619.36%−4.29
27 Feb 202623.65%+6.72
13 Feb 202616.93%−0.11
30 Jan 202617.04%+0.06
15 Jan 202616.98%+0.24
31 Dec 202516.74%+1.57
15 Dec 202515.17%+0.10
28 Nov 202515.07%−0.13
14 Nov 202515.20%+1.57
31 Oct 202513.63%+0.02
15 Oct 202513.61%+0.45
30 Sep 202513.16%−0.38
15 Sep 202513.54%+0.30
29 Aug 202513.24%+0.96
15 Aug 202512.28%−1.41
31 Jul 202513.69%−0.19
15 Jul 202513.88%−0.05
30 Jun 202513.93%+0.68
13 Jun 202513.25%+0.79
30 May 202512.46%−0.70
15 May 202513.16%+1.75
30 Apr 202511.41%+0.73
15 Apr 202510.68%+1.22
31 Mar 20259.46%+2.15
14 Mar 20257.31%−2.96
28 Feb 202510.27%−0.35
14 Feb 202510.62%+2.48
31 Jan 20258.14%−0.86
15 Jan 20259.00%−0.42
31 Dec 20249.42%−4.65
13 Dec 202414.07%+7.36
29 Nov 20246.71%+0.25
15 Nov 20246.46%+0.91
31 Oct 20245.55%+0.44
15 Oct 20245.11%+0.16
30 Sep 20244.95%−0.31
13 Sep 20245.26%0.00
30 Aug 20245.26%+0.18
15 Aug 20245.08%+4.53
28 Mar 20240.55%+0.42
30 Nov 20230.13%−0.01
15 Nov 20230.14%−0.10
31 Oct 20230.24%−0.31
13 Oct 20230.55%−0.01
29 Sep 20230.56%+0.01
15 Sep 20230.55%−0.02
31 Aug 20230.57%+0.01
15 Aug 20230.56%−0.04
31 Jul 20230.60%+0.05
14 Jul 20230.55%−0.02
30 Jun 20230.57%+0.10
15 Jun 20230.47%+0.04
31 May 20230.43%+0.25
14 Apr 20230.18%0.00
31 Mar 20230.18%+0.04
15 Mar 20230.14%+0.04
28 Feb 20230.10%0.00
15 Feb 20230.10%+0.02
31 Jan 20230.08%−0.02
13 Jan 20230.10%−0.01
30 Dec 20220.11%−0.07
15 Dec 20220.18%+0.05
30 Nov 20220.13%−0.02
15 Nov 20220.15%−0.01
31 Oct 20220.16%−0.01
14 Oct 20220.17%−0.03
30 Sep 20220.20%+0.02
15 Sep 20220.18%+0.01
31 Aug 20220.17%−0.01
15 Aug 20220.18%−0.02
29 Jul 20220.20%−0.02
15 Jul 20220.22%−0.02
30 Jun 20220.24%+0.02
15 Jun 20220.22%−0.10
31 May 20220.32%+0.11
13 May 20220.21%+0.03
29 Apr 20220.18%−0.07
14 Apr 20220.25%+0.04
31 Mar 20220.21%+0.03
15 Mar 20220.18%−0.03
28 Feb 20220.21%+0.04
15 Feb 20220.17%−0.01
31 Jan 20220.18%+0.02
14 Jan 20220.16%−0.03
31 Dec 20210.19%+0.06
15 Dec 20210.13%−0.02
30 Nov 20210.15%−0.02
15 Nov 20210.17%−0.10
29 Oct 20210.27%+0.04
15 Oct 20210.23%−0.09
30 Sep 20210.32%−0.16
15 Sep 20210.48%+0.27
31 Aug 20210.21%–

Newest first. Scroll inside the table for earlier dates, back to 31 Aug 2021.

Frequently asked questions

How shorted is Candel Therapeutics, Inc. right now?
16.13% of Candel Therapeutics, Inc.'s (CADL) shares outstanding were reported short for settlement date 15 Sep 2026, per FINRA's consolidated short interest report. That makes it the 253rd most shorted US stock, out of 3,805 we rank.
What does this number include?
FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?
US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Is this CADL's short float?
No. This is short interest as a percentage of shares outstanding, the count in the company's SEC filings. "Short float" divides the same FINRA short count by the public float, which excludes closely held shares, so it comes out higher for the same company. We publish no float estimates: the float is not a regulatory figure.
What is CADL's days to cover?
10.28 days for settlement date 15 Sep 2026: FINRA's own short interest ratio, the reported shares short divided by average daily trading volume. It is published in the same FINRA file and shown verbatim; we hold no volume data ourselves.
Which funds are short?
US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.